An open, dose-ranging, phase II trial of chlorproguanil/dapsone with three doses of artesunate for the treatment of acute uncomplicated Plasmodium Falciparum malaria
Wootton, D;
Opara, H;
Nyirenda, M;
Blencoe, H;
Kanjala, M;
Baldeh, I;
Woessners, M;
Neate, C;
Duparc, S;
Kirby, P;
+4 more...Milligan, P;
Molyneux, M;
Dunyo, S;
Winstanley, P;
(2005)
An open, dose-ranging, phase II trial of chlorproguanil/dapsone with three doses of artesunate for the treatment of acute uncomplicated Plasmodium Falciparum malaria.
[Conference or Workshop Item]
https://researchonline.lshtm.ac.uk/id/eprint/6470
Permanent Identifier
Use this permanent URL when citing or linking to this resource.
